GlassScriptPhysician profile
Lorenzo Lopez
NPI 1578566246
$1,582.05
in general payments reported to CMS, 2019-2025
22 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $346 · 2021: $12.13 · 2022: $61.56 · 2023: $163 · 2024: $326 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $232.23 | 2019-2020 | |
| Coopersurgical, INC. | $181.48 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $147.58 | 2020-2025 | Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $134.57 | 2024-2025 | |
| Organon LLC | $126.57 | 2023-2025 | Nexplanon |
| Exeltis, USA INC. | $102.04 | 2024 | Slynd |
| Allergan, INC. | $83.29 | 2019-2020 | |
| Therapeuticsmd, INC. | $69.20 | 2020 | |
| Merck Sharp & Dohme LLC | $68.97 | 2019-2024 | Gardasil, Gardasil 9 |
| Pfizer INC. | $63.38 | 2019-2024 | |
| Lupin INC. | $61.62 | 2019-2020 | |
| Covidien LP | $52.14 | 2019 | |
| Optumhealth Care Solutions, LLC | $40.38 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Agile Therapeutics, INC. | $37.38 | 2023-2024 | Twirla |
| Sage Therapeutics, LLC | $35.33 | 2019-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $26.93 | 2020-2021 | |
| Myovant Sciences INC. | $26.69 | 2022 | |
| Shield Therapeutics INC | $24.53 | 2025 | |
| Sumitomo Pharma America, INC. | $20.26 | 2025 | Myfembree |
| Octapharma USA, INC. | $17.19 | 2025 | Fibryga |
| Meditrina | $16.67 | 2024 | |
| Aspira Women'S Health INC | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorenzo Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.